Chemoradiation followed by adjuvant durvalumab in stage III non –small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone

ConclusionTreatment with adjuvant durvalumab following chemoradiation was associated with improved PFS and OS compared to chemoradiation alone.

Source: Thoracic Cancer - May 11, 2022 Category: Cancer & Oncology Authors: Akram Saad, Jeffrey Goldstein, Sarit Appel, Sameh Daher, Damien Urban, Amir Onn, Hadas Gantz ‐Sorotsky, Anastasiya Lobachov, Teodor Gottfried, Benjamin Spieler, Jair Bar Tags: ORIGINAL ARTICLE Source Type: research